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HIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak 
 
Many clinicians and researchers in the field of HIV medicine are aware of the outbreak of HIV 
infection that occurred in the rural town of Austin in Scott County, Indiana. It is fortunate that, to date, 
this outbreak has not been a harbinger of future outbreaks as many had predicted. For now, it is a 
cautionary tale, given the epidemic of injection drug use occurring in the United States today. 
 
The Evolution and Characteristics of the Indiana Outbreak 
At the end of 2014, just as the HIV outbreak in Indiana was beginning, an estimated 12,500 
people were living with HIV/AIDS the state, the majority of whom resided in urban areas, including the 
northwest part of the state (adjacent to Chicago) and Indianapolis (in the central part of the state). The 
outbreak occurred in Scott County, a small rural county approximately 80 miles southeast of Indianapolis. 
Over the prior 10 years, only 5 persons in Scott County were diagnosed with HIV infection. The epicenter 
of the outbreak was Austin, a small town with a population of approximately 4200. The town has a 10% 
unemployment rate, with 19% of the population living below the federal poverty line and 21% who did 
not graduate from high school. Scott County ranks last in life expectancy out of 92 counties in Indiana. 
It is estimated that there were more than 500 syringe-sharing partners in Scott County. Injection 
practices were multigenerational and injection equipment was commonly shared. Individuals diagnosed 
with HIV infection during the outbreak had an average of 9 high-risk syringe-sharing, sex, or social 
partners who needed to be tested for infection. The drug most commonly used was oxymorphone, in a 
reformulation available since 2012, which was crushed and injected. Oxymorphone produces a fixed but 
short-lived high, and individuals may inject the substance as many as 20 times per day.  
The outbreak was first identified in December 2014, when a physician in a town neighboring 
Austin observed within a short time frame that 2 individuals were HIV seropositive on screening. Another 
individual was soon diagnosed with HIV infection, and an astute disease intervention specialist was able 
to connect these cases with an additional 8 infected contacts by January 23, 2015. The Centers for Disease 
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Control and Prevention (CDC) was alerted in February 2015 by the Indiana State Department of Health, 
and in March a large number of disease intervention specialists were deployed door to door to trace the 
contacts who had so far been identified, in order to offer HIV testing. A public health emergency was 
declared on March 26, 2015, by which date there were 55 confirmed cases and 13 preliminary cases of 
HIV infection (all subsequently confirmed). The numbers of diagnoses per week are show in the Figure.  
By the end of the public health emergency order in June 2015, 170 individuals had been 
diagnosed with HIV infection. A total of 444 of 513 contacts had been located and offered HIV testing 
during the emergency order, and point-of-care rapid testing and a simultaneous blood draw for syphilis 
and hepatitis C virus (HCV) infection testing were provided. The overall rate of positive HIV test results 
among tested contacts in Scott County was 38%. Surveillance of high-risk individuals has continued, and 
by April 2016 there were 188 confirmed cases of HIV infection. Based on the estimate that 80% of the 
people diagnosed with HIV infection lived in Austin, the HIV prevalence rate in that town would be 
nearly 5%. The HIV-infected individuals had a median age of 34 years (range, 18-60 years), 58% were 
men, 100% were of white race, 92% (160/174) had HCV coinfection, and 95% had an annual income of 
less than $10,000; very few had private health insurance, with all others being enrolled in the expanded 
Indiana Medicaid program.  
Phylogenetic analysis of HIV polymerase sequences from the first 57 samples, performed by 
Galang and colleagues from the CDC, showed approximately 98% identity.1 Subsequent analysis of 157 
isolates by these investigators showed 99.7% identity, confirming that it was the introduction of a single 
case of HIV infection into this large, tight network of persons who inject drugs that precipitated this 
outbreak. Avidity testing indicated that all of the initially identified HIV infections had occurred within 
the previous 6 months, consistent with clinical and laboratory data from the first 73 individuals seen in 
the HIV clinic. Many individuals reported symptoms consistent with acute HIV infection in the past 1 to 
2 months prior to being evaluated in the clinic, and the elevated average CD4+ cell count (approximately 
650/µL) and plasma HIV RNA level (approximately 272,000 copies/mL) were consistent with early 
infection.  
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Containing the Outbreak 
Many services were initiated and maintained to contain the HIV outbreak in Indiana, including 
community-wide surveillance, contact tracing and door-to-door testing, targeting of high-risk populations, 
and outreach programs for transient populations. The county jail system implemented universal HIV 
screening at the start of the epidemic, which was instrumental in engaging otherwise difficult-to-reach 
individuals. Truck drivers working with the local canning industry who might be exposed through needle 
sharing or contact with sex workers were tested in an attempt to prevent the spread of HIV infection 
beyond county borders. Addiction treatment and harm-reduction services, including a syringe-exchange 
program and a program to administer preexposure prophylaxis (PrEP) were set up. No on-site, permanent 
addiction treatment services existed in Austin prior to the outbreak. Further, an HIV treatment program 
was implemented.  
Setting up these services was a multipronged effort coordinated by the Indiana State Department 
of Health, involving other state partners, federal partners (eg, the CDC, the Substance Abuse and Mental 
Health Services Administration, and the Health Resources and Services Administration), academic 
partners (eg, the Indiana University Schools of Medicine and Public Health), and local partners (eg, faith-
based organizations).  
The effort allowed for construction of what became known as the “One-Stop Shop,” located in a 
warehouse building in which the Community Outreach Center was established. The services offered at 
this site included HIV and HCV testing, vital records, drivers’ license and state ID services, insurance 
enrollment, immunizations, rehabilitation and mental health services, care coordination, the Department 
of Workforce Development, and a syringe-exchange program. Individuals were offered free 
transportation to the site, which was open 7 days per week with extended evening hours. Participants in 
the syringe-exchange program were issued unique ID cards and could complete exchanges weekly, during 
which they received sterile syringes, a wound kit, and referrals to health and substance use services. More 
than 28,000 needles were dispensed. The syringe-exchange program also featured a mobile unit, 
comprising 2 nurses tasked to drive through neighborhoods and offer clean syringes. In a study among the 
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first 100 participants in the syringe-exchange program, the proportion who shared syringes decreased 
from 34% to 5% over 3 months, with the median frequency of reuse declining from 4 times to 1 time; the 
proportion who shared syringes to divide drugs dropped from 38% to 10%; and the proportion who 
shared other injection equipment dropped from 44% to 11%.2 A key to the success of the syringe-
exchange program was the involvement of the community and of local law enforcement early in the 
process. 
Rehabilitation services offered included behavioral and drug rehabilitation and mental health 
services, including inpatient and outpatient services. Outpatient services are now available at a permanent 
site in Austin in a location that adjoins areas with the highest incidence of drug use. Additional services 
implemented during the emergency order included medication-assisted therapy (eg, increased access to 
naloxone and training programs for buprenorphine and naltrexone prescribing).  
During HIV testing, HIV-seronegative persons were informed about the needle-exchange 
program, referred for behavioral health services, and encouraged to undergo repeat HIV testing based on 
on-going exposure risks. Individuals found to be HIV infected began care coordination in the field and 
were referred for antiretroviral therapy.  
 
The Clinic 
Before the HIV outbreak in Austin, the nearest provider offering HIV care, a Ryan White 
HIV/AIDS Program–funded clinic, was 20 miles away. As the scope of the outbreak became apparent, the 
Indiana State Department of Health requested assistance from the Indiana University School of Medicine. 
Within 6 days, the Indiana University School of Medicine had set up a free clinic staffed with 2 infectious 
disease specialists in a borrowed space to provide HIV testing, treatment, education, and PrEP.  
Collaboration with local health care practitioners provided invaluable community-specific 
knowledge that facilitated locating difficult-to-find individuals, follow-up, and identifying individuals’ 
distinct needs. Local practitioners adopted unique roles in care, as not all wished to be involved in direct 
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HIV treatment, instead opting to focus on testing, counseling, or behavioral or mental health rehabilitation 
programs. Through such collaboration, an effective paradigm for local treatment and care was established. 
In the HIV clinic, in the absence of an electronic medical record system, paper intake forms were 
developed to obtain comprehensive medical histories. HIV treatment was prioritized and other aspects of 
care, such as pneumococcal vaccination and treatment of other medical issues, were staggered; the 
primary goals were to initiate antiretroviral treatment for as many HIV-infected individuals as possible as 
quickly as possible in order to reduce risks of continued HIV transmission. Educational materials were 
designed specifically for each visit, with emphasis on consistent messaging regarding treatment for all 
patients. Efforts to educate local pharmacists were also undertaken to ensure that they were 
knowledgeable with regard to antiretroviral treatment and associated adverse effects that might threaten 
adherence. 
At the clinic, individuals underwent insurance enrollment, basic laboratory testing, and physician 
assessment and counseling. Individuals with wild-type HIV genotypes and normal serum creatinine levels 
were prescribed 1 of 2 regimens: abacavir/lamivudine/dolutegravir (slash indicates a coformulation) for 
those who tested negative for the HLA-B*5701 allele or tenofovir/emtricitabine plus dolutegravir for 
those who tested positive for the HLA-B*5701 allele or were coinfected with hepatitis B virus. These 
regimens were selected for use on the basis of their tolerability and efficacy and to reduce the chances of 
drug-drug interactions with oxymorphone, medication-assisted treatment, and anti-HCV therapies. 
Individuals were asked to return to the clinic in 2 weeks to assess adherence and adverse effects and to 
address any barriers to treatment or ongoing care.  
Prominent themes that emerged during the effort to curtail the HIV outbreak and link infected 
individuals to care included the need for a wide range of knowledge (including local knowledge about the 
residents and community) and the needs to address stigma, to ensure privacy, and to emphasize long-term 
care. Every effort was made to provide a welcoming, nonjudgmental, and respectful environment for 
individuals to access HIV care, and this was instrumental in the success of the clinic and related 
programs. Word of mouth was important in bringing HIV-infected individuals into the clinic. 
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Coordination with the jail system to provide treatment, evaluation, and follow-up was also an important 
component of the community interventions; at any given time, approximately 10% to 20% of the HIV-
infected population in Austin is in short-term incarceration.  
Continuity of care remains challenging. At the end of 2015, among 176 individuals who were 
eligible for HIV treatment, 86% had been engaged in care, 74% had undergone care coordination, 59% 
had been prescribed antiretroviral therapy, and 32% had achieved virologic suppression. As of April 
2016, including incarcerated individuals receiving directly observed therapy, 52% of HIV-infected 
individuals had achieved virologic suppression. To date, cases of transmission are still being observed, 
indicating the need for amplification of harm-reduction measures. These efforts include an emphasis on 
increasing the availability of PrEP and improving uptake of PrEP in the community, which has been 
suboptimal thus far.  
 
Lessons Learned 
Community and practitioner awareness of the realities of injection drug use and HIV infection 
within the community is essential. Efforts of community programs and health care practitioners are 
crucial to engagement and retention in multidisciplinary HIV care. Treatment as prevention is 
fundamental to reducing HIV transmission. Program sustainability at the local level is vital and requires 
commitment and planning.  
The battle against the HIV outbreak in Indiana is ongoing. Not all HIV-infected individuals have 
been engaged in or retained in care; therefore, not all HIV-infected individuals have achieved virologic 
suppression. Ongoing efforts include coordination with the local jail system and inpatient and outpatient 
rehabilitation services. It remains a constant challenge to obtain resources for the local efforts and 
services necessary for a sustainable HIV care infrastructure.  
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Figures 
 
Figure. HIV diagnoses per week from late 2014 through July 2015 in Scott County, Indiana. Additional 
cases have been diagnosed since then. 
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